US0130911037 - Common Stock
Date | Firm | Action | Rating |
---|---|---|---|
2022-04-13 | Guggenheim | Maintains | Buy |
2022-04-13 | RBC Capital | Maintains | Outperform |
2022-04-13 | Goldman Sachs | Maintains | Neutral |
2022-04-13 | Morgan Stanley | Maintains | Underweight |
2022-04-11 | UBS | Maintains | Neutral |
2022-01-12 | Barclays | Maintains | Equal-Weight |
2022-01-12 | Morgan Stanley | Maintains | Underweight |
2022-01-07 | Telsey Advisory Group | Maintains | Outperform |
2021-12-14 | UBS | Initiate | Neutral |
2021-10-19 | RBC Capital | Maintains | Outperform |
2021-10-19 | Barclays | Maintains | Equal-Weight |
2021-10-19 | Telsey Advisory Group | Maintains | Outperform |
2021-10-19 | Citigroup | Downgrade | Buy -> Neutral |
2021-10-11 | Oppenheimer | Downgrade | Outperform -> Perform |
2021-10-05 | BMO Capital | Downgrade | Market Perform -> Underperform |
2021-09-23 | Credit Suisse | Maintains | Outperform |
2021-08-11 | Tigress Financial | Downgrade | Buy -> Neutral |
2021-08-11 | Barclays | Upgrade | Underweight -> Equal-Weight |
2021-08-11 | Telsey Advisory Group | Maintains | Outperform |
2021-08-02 | Morgan Stanley | Maintains | Underweight |
2021-07-30 | Telsey Advisory Group | Maintains | Outperform |
2021-07-30 | Credit Suisse | Maintains | Outperform |
2021-05-04 | Goldman Sachs | Downgrade | Buy -> Neutral |
2021-05-03 | Morgan Stanley | Maintains | Underweight |
2021-04-29 | Morgan Stanley | Maintains | Underweight |
2021-04-27 | Credit Suisse | Maintains | Outperform |
Find the competitors with the best analyst ratings on the USA